Cargando…
How to define a cut-off value of tumour markers in haemodialysis patients?
Autores principales: | Mercadal, Lucile, Cormont, Sylvie, Tezenas-du-Montcel, Sophie, Hacini, Sabria, Venditto, Marcia, Deray, Gilbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421335/ https://www.ncbi.nlm.nih.gov/pubmed/25949331 http://dx.doi.org/10.1093/ndtplus/sfn216 |
Ejemplares similares
-
Clinical review: Use of vancomycin in haemodialysis patients
por: Launay-Vacher, Vincent, et al.
Publicado: (2002) -
Protein loss and medium cut-off haemodialysis
por: Belmouaz, Mohamed, et al.
Publicado: (2019) -
High cut-off dialyser haemodialysis in cast nephropathy
por: Li Cavoli, Gioacchino, et al.
Publicado: (2012) -
The role of dysregulated ghrelin/LEAP-2 balance in eating disorder: a translational study in anorexia nervosa.
por: Tezenas du Montcel, C.
Publicado: (2023) -
Impact of lean mass and bone density on glomerular filtration rate estimation in people living with HIV/AIDS
por: Isnard Bagnis, Corinne, et al.
Publicado: (2017)